Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/53606
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Shimada, Masayuki | |
dc.contributor.author | Hernandez-Gonzalez, Inmaculada | |
dc.contributor.author | Gonzalez-Robayna, Ignacio | |
dc.contributor.author | Richards, JoAnne S. | |
dc.contributor.other | Hernandez Gonzalez, Inmaculada | |
dc.contributor.other | Shimada, Masayuki | |
dc.contributor.other | Gonzalez Robayna, Ignacio | |
dc.date.accessioned | 2019-02-04T17:24:07Z | - |
dc.date.available | 2019-02-04T17:24:07Z | - |
dc.date.issued | 2006 | |
dc.identifier.issn | 0888-8809 | |
dc.identifier.uri | http://hdl.handle.net/10553/53606 | - |
dc.description.abstract | The molecular bridges that link the LH surge with functional changes in cumulus cells that possess few LH receptors are being unraveled. Herein we document that epidermal growth factor ( EGF)- like factors amphiregulin ( Areg), epiregulin ( Ereg), and betacellulin ( Btc) are induced in cumulus oocyte complexes ( COCs) by autocrine and paracrine mechanisms that involve the actions of prostaglandins ( PGs) and progesterone receptor ( PGR). Areg and Ereg mRNA and protein levels were reduced significantly in COCs and ovaries collected from prostaglandin synthase 2 ( Ptgs2) null mice and Pgr null ( PRKO) mice at 4 h and 8 h after human chorionic gonadotropin, respectively. In cultured COCs, FSH/forskolin induced Areg mRNA within 0.5 h that peaked at 4 h, a process blocked by inhibitors of p38MAPK ( SB203580), MAPK kinase (MEK) 1 ( PD98059), and PTGS2 ( NS398) but not protein kinase A ( PKA) ( KT5720). Conversely, AREG but not FSH induced Ptsg2 mRNA at 0.5 h with peak expression of Ptgs2 and Areg mRNAs at 4 h, processes blocked by the EGF receptor tyrosine kinase inhibitor AG1478 ( AG), PD98059, and NS398. PGE2 reversed the inhibitory effects of AG on AREG-induced expression of Areg but not Ptgs2, placing Ptgs2 downstream of EGF-R signaling. Phorbol 12- myristate 13-acetate (PMA) and adenovirally expressed PGRA synergistically induced Areg mRNA in granulosa cells. In COCs, AREG not only induced genes that impact matrix formation but also genes involved in steroidogenesis ( StAR, Cyp11a1) and immune cell-like functions (Pdcd1, Runx1, Cd52). Collectively, FSH-mediated induction of Areg mRNA via p38MAPK precedes AREG induction of Ptgs2 mRNA via ERK1/2. PGs acting via PTGER2 in cumulus cells provide a secondary, autocrine pathway to regulate expression of Areg in COCs showing critical functional links between G protein- coupled receptor and growth factor receptor pathways in ovulating follicles. | |
dc.publisher | 0888-8809 | |
dc.relation.ispartof | Molecular Endocrinology | |
dc.source | Molecular Endocrinology[ISSN 0888-8809],v. 20 (6), p. 1352-1365 | |
dc.subject.other | Follicle-Stimulating-Hormone | |
dc.subject.other | Ribonucleic-Acid Expression | |
dc.subject.other | Luteinizing-Hormone | |
dc.subject.other | Endoperoxide Synthase-2 | |
dc.subject.other | Mice Lacking | |
dc.subject.other | Meiotic Resumption | |
dc.subject.other | Ovarian-Follicles | |
dc.subject.other | Gene-Expression | |
dc.subject.other | Family-Members | |
dc.subject.other | Protein | |
dc.title | Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: Key roles for prostaglandin synthase 2 and progesterone receptor | |
dc.type | info:eu-repo/semantics/Article | |
dc.type | Article | |
dc.identifier.doi | 10.1210/me.2005-0504 | |
dc.identifier.scopus | 33744464493 | |
dc.identifier.isi | 000237806900017 | |
dcterms.isPartOf | Molecular Endocrinology | |
dcterms.source | Molecular Endocrinology[ISSN 0888-8809],v. 20 (6), p. 1352-1365 | |
dc.contributor.authorscopusid | 56212657200 | |
dc.contributor.authorscopusid | 13807439800 | |
dc.contributor.authorscopusid | 6507425244 | |
dc.contributor.authorscopusid | 7403707010 | |
dc.description.lastpage | 1365 | |
dc.identifier.issue | 6 | |
dc.description.firstpage | 1352 | |
dc.relation.volume | 20 | |
dc.type2 | Artículo | |
dc.identifier.wos | WOS:000237806900017 | |
dc.contributor.daisngid | 404030 | |
dc.contributor.daisngid | 2446020 | |
dc.contributor.daisngid | 2922182 | |
dc.contributor.daisngid | 63955 | |
dc.contributor.daisngid | 29401747 | |
dc.identifier.investigatorRID | K-7776-2014 | |
dc.identifier.investigatorRID | Q-3673-2016 | |
dc.identifier.investigatorRID | K-9671-2014 | |
dc.contributor.wosstandard | WOS:Shimada, M | |
dc.contributor.wosstandard | WOS:Hernandez-Gonzalez, I | |
dc.contributor.wosstandard | WOS:Gonzalez-Robayna, I | |
dc.contributor.wosstandard | WOS:Richards, JAS | |
dc.date.coverdate | Junio 2006 | |
dc.identifier.ulpgc | Sí | es |
dc.description.jcr | 4,967 | |
dc.description.jcrq | Q1 | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.orcid | 0000-0001-8937-9034 | - |
crisitem.author.orcid | 0000-0002-7650-4454 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Hernández González, Inmaculada Servanda | - |
crisitem.author.fullName | González Robayna, Ignacio Javier | - |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.